000 01563 a2200457 4500
005 20250517170848.0
264 0 _c20180720
008 201807s 0 0 eng d
022 _a2235-3186
024 7 _a10.1159/000479390
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCoene, Karlien L M
245 0 0 _aPractical Value of Anti-Xa Activity in the Evaluation of Extracorporeal Circuit Anticoagulation during Haemodialysis: Results of a Cross-Sectional Single-Centre Study.
_h[electronic resource]
260 _bNephron
_c2017
300 _a205-211 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aCohort Studies
650 0 4 _aCross-Sectional Studies
650 0 4 _aFactor Xa
_xdrug effects
650 0 4 _aFactor Xa Inhibitors
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHeparin, Low-Molecular-Weight
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xphysiopathology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNetherlands
650 0 4 _aPartial Thromboplastin Time
650 0 4 _aRenal Dialysis
700 1 _aDekker, Marijke J E
700 1 _aKerskes, Marieke C H M
700 1 _aHengst, Maaike
700 1 _aSchonck, Marc J M
700 1 _aKonings, Constantijn J A M
700 1 _aScharnhorst, Volkher
773 0 _tNephron
_gvol. 137
_gno. 3
_gp. 205-211
856 4 0 _uhttps://doi.org/10.1159/000479390
_zAvailable from publisher's website
999 _c27475046
_d27475046